Question 1

What is LOPJLB’s current signal on GTBP?

Accepted Answer

LOPJLB’s latest quantitative signal on GT Biopharma, Inc. (GTBP) is SELL in a CRISIS regime. Signals are updated daily.

Question 2

What market regime is GTBP in?

Accepted Answer

GT Biopharma, Inc. (GTBP) is currently classified in the CRISIS HMM market regime on LOPJLB.

Question 3

What does GT Biopharma, Inc. (GTBP) do?

Accepted Answer

GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. Their innovative approach centers on a proprietary technology platform called Tri-specific Killer Engager (TriKE) fusion proteins, which are designed to harness the body's immune cells. Central to their pipeline is GTB-3550, a sin…

Question 4

Where is GT Biopharma, Inc. based / listed?

Accepted Answer

GT Biopharma, Inc. is based in US, listed on NASDAQ.

GT Biopharma, Inc. (GTBP)

Key stats

Prediction markets

Company news